Fifty-one patients suffering an acute episode of schizophrenia and treated with aripiprazole long-acting injectable (ALAI) were chosen to elaborate an observational study in two in-patient units in Spain, in order to examine the effects of early administration during a hospital admission. When treatment with ALAI is administered in the first week of admission (in 31 patients, 60.78%), hospitalization time is significantly reduced, 12.1 days on average. It can be concluded that ALAI is an effective treatment for these patients. Analysis in economic terms and comparison with other LAI antipsychotics are interesting lines for further research.

中文翻译：

---

阿立哌唑长效注射剂在急性住院精神分裂症患者中的早期给药：临床报告。

选择了 51 名患有急性精神分裂症并接受阿立哌唑长效注射剂 (ALAI) 治疗的患者，在西班牙的两个住院病房中详细阐述了一项观察性研究，以检查入院期间早期给药的效果. 在入院第一周进行 ALAI 治疗时（31 名患者，60.78%），住院时间显着缩短，平均 12.1 天。可以得出结论，ALAI对这些患者是一种有效的治疗方法。经济方面的分析以及与其他 LAI 抗精神病药的比较是进一步研究的有趣方向。